Introductory lecture: Allosteric modulation of torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 42007, 1997, Pages 11-28

  Maelicke, Alfred ^a   Coban, Thomas ^a   Storch, Alexander ^a   Schrattenholz, André ^a   Pereira, Edna F r ^b   Albuquerque, Edson X ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ION CHANNEL; LIGAND; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ALLOSTERISM; ANIMAL TISSUE; BINDING SITE; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CHOLINERGIC TRANSMISSION; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; ELECTROPHYSIOLOGY; ION CURRENT; MEMBRANE VESICLE; NEUROTRANSMISSION; NONHUMAN; PROTEIN STRUCTURE; TORPEDO;

ANIMALS; CALCIUM; CESIUM; CODEINE; DRUG SYNERGISM; ELECTROPHYSIOLOGY; GALANTAMINE; ISOFLUROPHATE; KINETICS; MICROSCOPY, PHASE-CONTRAST; NICOTINIC AGONISTS; PHYSOSTIGMINE; RECEPTORS, NICOTINIC; TORPEDO;

EID: 0031034430     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709036592     Document Type: Article

References (29)

1. Okonjo K. O., Kuhlmann J., Maelicke A. A second pathway of activation of the Torpedo acetylcholine receptor channel. Eur. J. Biochem. 1991; 200: 671 – 677
2. Kuhlmann J., Okonjo K. O., Maelicke A. Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel. FEBS Lett. 1991; 279: 216 – 218
3. Schrattenholz A., Godovac-Zimmermann J., Schäfer H.-J., Albuquerque E. X., Maelicke A. Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine. Eur. J. Biochem. 1993; 216: 671 – 677
4. Schröder B., Reinhardt S., Schrattenholz A., McLane K. E., Kretschmer A., Conti-Tronconi B. M., Maelicke A. Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo acetylcholine receptor α-polypeptide. J. Biol. Chem. 1994; 269: 10407 – 10416
5. Shaw K. P., Aracava Y., Akaide A., Daly J. W., Rickett D. L., Albuquerque E. X. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonistic effects on the acetylcholine receptor-ion channel complex. Mol. Pharmacol. 1985; 28: 527 – 538
6. Albuquerque E. X., Aracava Y., Cintra W. M., Brossi A., Schönenberger B., Deshpande S. S. Structure-activity relationship of reversible cholinesterase inhibitors: Activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex. Braz. J. Med. Res. 1988; 21: 1173 – 1196
7. Maelicke A., Coban T., Schrattenholz A., Schröder B., Reinhardt S., Storch A., Godovac-Zimmermann J., Methfessel C., Pereira E. F. R., Albuquerque E. X. Physostigmine and neuromuscular transmission. Ann. N. Y. Acad. Sci. 1993; 681: 140 – 154
8. Pereira E. F. R., Reinhardt S., Schrattenholz A., Maelicke A., Albuquerque E. X. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 1993; 265: 1474 – 1491
9. Pereira E. F. R., Alkondon M., Reinhardt S., Maelicke A., Peng X., Lindstrom J., Whiting P., Albuquerque E. X. Physostigmine and galanthamine characterize the presence of the novel binding site on the α482 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells. J. Pharmacol. Exp. Ther. 1994; 270: 768 – 778
10. Storch A., Schrattenholz A., Cooper J. C., Gutbrod O., Weber K.-H., Reinhardt S., Lobron C., Hermsen B., Soskic V., Pereira E. F. R., Albuquerque E. X., Methfessel C., Maelicke A. Physostigmine, galanthamine and codeine act as noncompetitive nicotinic receptor agonists on clonal rat pheochromocytoma cells. Eur. J. Pharmacol. 1995; 290: 207 – 219
11. Schrattenholz A., Pereira E. F. R., Roth U., Weber K.-H., Albuquerque E. X., Maelicke A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 1996; 49: 1 – 6
12. Fels G., Plümer-Wilk R., Schreiber M., Maelicke A. A monoclonal antibody interfering with binding and response of the acetylcholine receptor. J. Biol. Chem. 1986; 261: 15746 – 15754
13. Albuquerque E. X., Pereira E. F. R., Castro N. G., Alkondon M., Reinhardt S., Schröder H., Maelicke A. Nicotinic receptor function in the mammalian central nervous system. Ann. N. Y. Acad. Sci. 1995; 757: 48 – 72
14. Reinhardt S., Schmiady H., Tesche B., Hucho F. Functional and structural analysis of acetylcholine receptor-rich membranes after negative staining. FEBS Lett. 1984; 173: 217 – 221
15. Prinz H., Veltel D. Variations in binding affinities of peripheral nicotinic acetylcholine receptor can be attributed to endogenous acetylcholine. Biol. Chem. Hoppe-Seyler 1988; 369: 1243 – 1249
16. Forman S. A., Miller K. W. Molecular sites of anaesthetic action in postsynaptic nicotinic membranes. Trends Pharmacol. Sci. 1989; 10: 447 – 452
17. Garty F., Rudy B., Karlish S. J. A simple and sensitive procedure for measuring isotope fluxes through ion-specific channels in heterogenous populations of membrane vesicles. J. Biol. Chem. 1983; 258: 13094 – 13099
18. Moore H.-P. H., Raftery M. A. Direct spectroscopic studies of cation translocation by Torpedo acetylcholine receptor on a time scale of physiological relevance. Proc. Natl. Acad. Sci. USA 1980; 77: 4509 – 4513
19. Riquelme G., Lopez E., Garcia-Segura L. M., Ferragut J. A., Gonzales-Ros J. M. Giant liposomes: A model system in which to obtain patch-clamp recordings of ionic channels. Biochemistry 1990; 29: 11215 – 11222
20. Johnston J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325: 529 – 531
21. McBain C. J., Mayer M. L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 1994; 74: 723 – 760
22. Prinz H., Maelicke A. Ligand-binding to the membrane-bound acetylcholine receptor from Torpedo marmorata: A complete mathematical analysis. Biochemistry 1992; 31: 6728 – 6738
23. Prinz H., Maelicke A. Interaction of cholinergic ligands with the purified acetylcholine receptor protein. J. Biol. Chem. 1983; 258: 10263 – 10271
24. Hebb D. O. The organization of behaviour: A Neuropsychological Approach. John Wiley & Sons, Inc., New York 1949
25. Schröder H., Giacobini E., Strubble R. G., Zilles K., Maelicke A. Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiol. Aging 1991; 12: 259 – 262
26. Whitehouse P. J., Martino A. M., Wagster M. V., Price D. L., Mayeux R., Atack J. R., Kellar K. J. Reduction in [3H]-nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autoradiographic study. Neurology 1988; 38: 720 – 723
27. Fambrough D. M., Drachman D. B., Styamurti S. Neuro-muscular junction in Myasthenia gravis: Decreased acetylcholine receptors. Science 1973; 182: 293 – 295
28. Maelicke A., Albuquerque E. X. New approach to drug therapy in Alzheimer's dementia. Drug Disc. Today 1996; 1: 53 – 59
29. Thal L. J., Fuld P. A., Masur D. M., Sharpless N. A. Oral physostigmine and lecithine improve memory in Alzheimer's disease. Ann. Neurol. 1983; 13: 491 – 496